FDA-filed SPL labeling · retrieved through openFDA

Triamcinolone

Triamcinolone is a corticosteroid used across multiple forms and routes to treat inflammation, allergic conditions, skin disorders, joint pain, eye diseases, and nasal allergy symptoms.

Brand names AristocortKenacortKenalogOraloneTriderm +11 more
Drug class ⓘ Corticosteroid
Rx/OTC Forms 6 Routes Topical · Intra-articular, Intramuscular · Nasal · Intra-articular; Intramuscular +10
Dr. Brian Staiger, PharmD, BCPS
Reviewed by Last reviewed Jul 10, 2026
🧬 Where this information comes from Click to expand

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 147 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →

At a glance
Linked label effectiveJan 28, 2026
Clinical labels in scope ⓘ147
AvailabilityRx/OTC
Earliest approval/marketing year ⓘ1957
FDA-listed product records ⓘ636
Boxed warningNone found in compared labels
How we combine label and product data →
Other forms & routes:
⭐ Triamcinolone at a glance The quick version — the full detail is in the Patient Information Guide below.
💊
HelloPharmacist Editorial Team Bottom Line
Triamcinolone is a powerful anti-inflammatory corticosteroid available in many forms, from joint injections and skin creams to nasal sprays and eye injections, each approved for specific conditions. It works well but comes with real risks — especially around immune suppression, blood sugar, and adrenal function — so it's always used at the lowest dose that controls your condition. Keep all follow-up appointments, tell every provider you're using it, and never stop an injectable or systemic form abruptly without guidance.

📖 Triamcinolone: Patient Information Guide

A plain-language walkthrough of Triamcinolone — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.

🎯What it's used for▾

Triamcinolone is a corticosteroid used across many delivery forms for inflammation, allergic conditions, skin diseases, joint disorders, eye conditions, and nasal allergy relief.

  • Intramuscular injection (e.g., Kenalog-40, triamcinolone acetonide injectable suspension): Severe allergic conditions (asthma, severe skin allergies, drug reactions, serum sickness, allergic rhinitis, transfusion reactions); serious skin diseases (pemphigus, Stevens-Johnson syndrome, mycosis fungoides, bullous dermatitis herpetiformis, exfoliative erythroderma); endocrine disorders (adrenocortical insufficiency, congenital adrenal hyperplasia, cancer-related hypercalcemia); and other serious inflammatory conditions when oral therapy is not possible.
  • Intra-articular / soft tissue injection (e.g., Kenalog-10, triamcinolone acetonide injectable suspension): Short-term relief for acute gouty arthritis, bursitis, tenosynovitis (tendon sheath inflammation), epicondylitis, rheumatoid arthritis, and osteoarthritis synovitis.
  • Intralesional injection (e.g., Kenalog-10, triamcinolone acetonide injectable suspension): Alopecia areata (patchy hair loss), keloids, discoid lupus erythematosus, psoriatic plaques, lichen planus, lichen simplex chronicus, granuloma annulare, necrobiosis lipoidica diabeticorum, and cystic tendon or joint tumors (ganglia).
  • Triesence (ophthalmic / intravitreal injection): Eye diseases — sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions not responding to eye-drop steroids; also used to aid visualization during vitrectomy (eye surgery).
  • Topical creams, ointments, lotions, aerosol spray (triamcinolone acetonide, Triderm): Relief of itching and inflammation from corticosteroid-responsive skin conditions (dermatoses).
  • Dental paste (Oralone, Kourzeq, triamcinolone acetonide dental paste): Adjunctive treatment and symptom relief of painful mouth sores (oral inflammatory and traumatic ulcerative lesions).
  • Nasal spray (Good Sense Nasal Allergy, Nasal Allergy Relief, and other OTC brands): Temporary relief of hay fever and upper respiratory allergy symptoms — nasal congestion, runny nose, sneezing, and itchy nose.
⚙️How it works▾

Triamcinolone binds to glucocorticoid receptors inside cells, switching on proteins (called lipocortins) that block inflammation and switching off the chemical signals — specifically prostaglandins and leukotrienes — that cause swelling, redness, and pain. It also modulates the immune system more broadly, which is why it works across such a wide range of inflammatory and allergic conditions.

Because it acts on the immune system, triamcinolone can suppress the body's normal defenses at higher doses. This is the trade-off that drives most of its important warnings.

💊How it's taken▾

Triamcinolone is available in many forms, and how it is taken is very specific to the form and condition being treated.

  • Injectable forms (intramuscular, intra-articular, intralesional): Always given by a healthcare provider. Doses are individualized and adjusted over time to find the lowest effective amount. Not suitable for intravenous use.
  • Triesence (ophthalmic injection): Given by an eye specialist directly into the eye, with dosing tailored to the indication.
  • Topical (cream, ointment, lotion, aerosol): Applied in a thin layer to the affected skin area typically two to four times daily, depending on the strength and formulation.
  • Nasal spray (OTC): Adults and children 12 and older use two sprays per nostril once daily, reducing to one spray per nostril once symptoms improve. Children 6 to under 12 use one spray per nostril daily under adult supervision.
  • Dental paste: Applied directly to mouth sores as directed by your prescriber or dentist.

Always follow your prescriber's instructions. Doses are never one-size-fits-all with triamcinolone.

🤒Side effects — in detail▾

Side effects vary by formulation and dose, but here are the most commonly reported ones:

  • Sinusitis (sinus inflammation)
  • Cough
  • Bruising near the injection site
  • Joint swelling after intra-articular injection
  • Joint pain (arthralgia), especially after a second injection
  • Elevated blood glucose (blood sugar), particularly in people with diabetes
  • Headache
  • Skin thinning, discoloration, or local tissue shrinkage at injection or application sites

Seek medical help right away if you experience signs of a serious allergic reaction (throat swelling, difficulty breathing), signs of joint infection (fever, severe swelling), sudden vision changes, or new mood or behavior changes — these require prompt attention.

⚠️Warnings & precautions▾
  • Immune suppression and infection risk: Triamcinolone reduces your immune defenses. Any infection — bacterial, viral, fungal, or parasitic — can become more serious. It can also hide infection signs. Avoid people with chickenpox or measles if you haven't had them. Live vaccines should not be given during immunosuppressive treatment.
  • Adrenal suppression: After extended use, your adrenal glands may slow their own hormone production. Stopping abruptly or facing illness/surgery without extra steroid coverage can trigger a crisis. Always taper under medical guidance and tell any surgeon you are on or recently stopped corticosteroids.
  • Serious neurologic events with epidural/intrathecal injection: Giving corticosteroids into or around the spine can cause stroke, paralysis, blindness, and death. Triamcinolone injectable suspension is NOT approved for epidural or intrathecal use.
  • Hepatitis B reactivation: Patients who carry hepatitis B virus can experience dangerous reactivation. Screening before prolonged treatment is recommended.
  • Mood and psychiatric effects: Corticosteroids can cause euphoria, insomnia, mood swings, depression, or more serious psychiatric symptoms. Report any new or worsening mental health changes promptly.
  • Bone loss and eye pressure: Long-term use can weaken bones and raise pressure inside the eye (risking glaucoma and cataracts). Regular monitoring is important.
  • Blood sugar: Triamcinolone raises blood glucose, which is a particular concern for people with diabetes or prediabetes.
🔀What it interacts with▾

Triamcinolone can interact with several medications in meaningful ways:

  • Strong CYP3A4 inhibitors (ritonavir, ketoconazole, clarithromycin, itraconazole, and others) — slow down how the body breaks down triamcinolone, raising its levels and increasing side effects.
  • Warfarin — corticosteroids generally weaken warfarin's blood-thinning effect; INR should be monitored closely.
  • Diabetes medications — triamcinolone raises blood sugar, so insulin or oral diabetes drug doses may need to be adjusted.
  • Potassium-depleting drugs (certain diuretics, amphotericin B) — combined use can drop potassium to dangerous levels; risk of heart arrhythmias, especially with digoxin.
  • Cyclosporine — both drugs become more active together; seizures have been reported.
  • Macrolide antibiotics (e.g., clarithromycin, erythromycin) — reduce clearance of triamcinolone, increasing exposure and side effects.
  • NSAIDs and aspirin — increases risk of stomach ulcers and GI bleeding when used together.
  • Live vaccines — should not be administered during immunosuppressive steroid therapy; immune response to inactivated vaccines may also be reduced.

This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.

📋Before taking it▾
  • Tell your doctor if you have ever had an allergic reaction to triamcinolone or any other corticosteroid.
  • Pregnant or planning pregnancy: Animal studies showed birth defects at doses below the human recommended dose. The risk to humans is not fully known; discuss with your provider before use.
  • Breastfeeding: Corticosteroids have been detected in breast milk. The impact of triamcinolone specifically is not known; weigh benefits and risks with your provider.
  • Diabetes: Triamcinolone raises blood sugar — your diabetes medications may need adjustment and blood glucose should be monitored closely.
  • Active or latent infections (including TB, hepatitis B, fungal infections, amebiasis, Strongyloides): These can worsen or reactivate. Screening and close monitoring are needed.
  • Heart failure, high blood pressure, or kidney problems: Triamcinolone can cause fluid retention and raise blood pressure; monitoring of weight, blood pressure, and electrolytes is recommended.
  • Osteoporosis or bone loss risk (e.g., postmenopausal women): Long-term use can further weaken bones.
  • History of psychiatric illness: Corticosteroids can trigger or worsen mood and psychiatric symptoms.
  • Stomach ulcers, inflammatory bowel disease, or recent bowel surgery: Risk of GI perforation is increased.
  • Children: Can slow growth; height and weight should be monitored regularly. Safety of ZILRETTA has not been established in pediatric patients.
  • Older adults: No specific dose changes required, but older individuals may be more sensitive to side effects.
🚑If you take too much▾

Acute overdose of triamcinolone is treated with supportive and symptom-focused care — there is no specific antidote. For patients on long-term corticosteroid therapy who have received too much over time, the dose may be carefully and gradually reduced, or an every-other-day schedule may be considered, always under close medical supervision.

📡Pharmacodynamics — effects in the body▾

After a single intramuscular dose of triamcinolone acetonide injectable suspension, the adrenal glands (which normally make the body's own cortisol) begin to suppress their output within 24 to 48 hours. They gradually return to normal function over roughly 30 to 40 days. For ZILRETTA (the extended-release intra-articular form), adrenal suppression begins within 12 to 24 hours of a knee injection and normalizes within 30 to 42 days. Triamcinolone can raise blood glucose; in a small study of patients with controlled type 2 diabetes who received a single ZILRETTA injection, average blood sugar rose modestly over the following 72 hours.

🔬Pharmacokinetics — how your body processes it▾

ZILRETTA is a special extended-release formulation: tiny microspheres made of a biodegradable polymer (PLGA) slowly release triamcinolone acetonide after injection into the knee joint. Compared to the same dose of immediate-release triamcinolone injected into the knee, ZILRETTA reaches a much lower peak blood concentration — roughly 18 times lower — reducing the amount that spills into the bloodstream. The half-life (time for blood levels to fall by half) of ZILRETTA is approximately 634 hours, compared to about 147 hours for the immediate-release injection, reflecting its slow, sustained release from the joint.

📦How to store it▾

Store at 20-25°C (68-77°F) .

📄 Written from Triamcinolone’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →

124

Supplements & herbs that interact with Triamcinolone

124 supplements and herbal products have documented interactions with Triamcinolone in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.

Severity mix
  • Major · 3
  • Moderate · 102
  • Minor · 19
Every supplement checked against Triamcinolone — ranked by severity The full interaction hub: 3 major · 102 moderate · 19 minor · every one linked to its full report. Check Triamcinolone against your exact supplements

Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.

8

Nutrient depletion considerations

Triamcinolone has been associated with lower levels of 8 nutrients in the clinical literature. This does not mean a deficiency will occur — it means these may be worth discussing with your pharmacist or healthcare provider, especially with long-term use.

Evidence & significance mix
  • Higher significance · 1
  • Moderate · 5
  • Unrated · 2
See the full Triamcinolone nutrient depletion report

Educational information from a licensed clinical database (Natural Medicines) — not medical advice. Do not start or stop medications or supplements without professional guidance.

🩺 Pharmacist Counseling Corner

Quick, plain-English answers to the questions patients ask most about Triamcinolone — the kind of thing our pharmacy team would talk through with you at the counter.

I'm getting a triamcinolone injection in my knee. Will it actually help, and how long does it last? ▾
Yes, intra-articular triamcinolone is specifically approved to give short-term relief for knee arthritis, gout flares, bursitis, and similar joint conditions. The extended-release form (ZILRETTA) is designed to release slowly over weeks, which helps reduce the amount that reaches your bloodstream. The exact duration varies from person to person, so keep your follow-up appointment so your provider can gauge how you're responding.
I have diabetes. Should I be worried about using triamcinolone? ▾
That's a really important thing to flag with your doctor before your injection or prescription. Triamcinolone can raise blood sugar — even in people whose diabetes is well-controlled. If you're using an injectable or systemic form, your glucose should be monitored more closely in the days after your dose. Your diabetes medication dose may need a temporary adjustment. Don't skip your glucose checks during this time.
What should I watch out for after a joint injection — when do I need to call my doctor? ▾
A little soreness right after the injection is normal. What you want to call your doctor about is if the joint gets significantly more painful, swollen, warm, or stiff — especially if you develop a fever. That combination could indicate a joint infection, which needs to be treated right away. Also call if you notice signs of a serious allergic reaction: hives, throat tightening, or trouble breathing.
Can I use the nasal spray every day? My kid is 8 — is it safe for them? ▾
The OTC triamcinolone nasal spray is designed for once-daily use, and it can be used in children ages 6 and up with an adult supervising. Start with one spray per nostril daily; if symptoms don't improve, your provider may recommend two. The one thing to know for kids is that corticosteroid nasal sprays can occasionally slow growth rate if used for extended periods. If your child needs the spray for more than two months a year, check in with their doctor to make sure everything looks on track.
I've been on injectable triamcinolone for a while. Can I just stop taking it? ▾
You shouldn't stop abruptly without talking to your prescriber, especially if you've been using injectable or systemic forms for more than a short time. Corticosteroids tell your adrenal glands to slow down their own hormone production. If you stop suddenly, your body may not make enough cortisol on its own — this is called adrenal insufficiency, and it can be serious, particularly during illness or surgery. Your doctor will guide you on how to taper down safely.
I'm pregnant. Is it safe to use the triamcinolone cream on my skin? ▾
It's a reasonable question. Animal studies with triamcinolone showed some risk of birth defects, though most of that research involved injected forms at relatively high doses. The human evidence is limited and mainly from oral, topical, and inhaled steroids. Your doctor needs to weigh the benefit of treating your skin condition against any potential risk for your pregnancy. Don't stop or start anything without that conversation — but do have it soon.
Is Triamcinolone available over the counter? ▾
Both — Triamcinolone is sold both over the counter and by prescription, according to its FDA labeling. Lower strengths or certain forms are often available without a prescription, while higher strengths or specialized forms still require one. Ask your pharmacist which version is right for you.
When was Triamcinolone first available? ▾
Triamcinolone has been available in the United States since at least 1957, based on FDA approval history (Drugs@FDA) and product marketing records.
Who makes Triamcinolone? ▾
Triamcinolone is supplied by 134 manufacturers listed in the FDA NDC Directory, including Bryant Ranch Prepack, A-S Medication Solutions, NuCare Pharmaceuticals,Inc..

💬 Answers drafted from Triamcinolone’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →

🧰 Keep exploring

💊 How Triamcinolone comes

Triamcinolone is available in 6 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.

Injection

By injection · In the eye · Into a joint · Into a muscle · Intra-Arterial · Intralesional · Soft Tissue
Brands Hexatrione Triamcinolone Acetonide Triesence Xipere
Available strengths 7 strengths
Show 1 more strength Show fewer strengths
140 FDA-listed product records ⓘ

Nasal spray

In the nose
Brands Nasacort Triamcinolone acetonide
Available strengths 1 strength
54 FDA-listed product records ⓘ

Inhaler

On the skin
Brands Kenalog Triamcinolone Acetonide
Available strengths 1 strength
9 FDA-listed product records ⓘ

Spray

By mouth
Available strengths 2 strengths
4 FDA-listed product records ⓘ

Oral suspension

By mouth
Available strengths 1 strength
1 FDA-listed product record ⓘ

📊 Triamcinolone across the U.S. market

How Triamcinolone appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

6
Dose forms ⓘ
134
Manufacturers
40
Brand names
636
FDA-listed product records ⓘ
1957
First marketed ⓘ

FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

Also listed with the FDA, not a patient dose form: Powder (35) · Kit (10) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.

Bryant Ranch Prepack13%
A-S Medication Solutions10%
NuCare Pharmaceuticals,Inc.7%
Amneal Pharmaceuticals LLC7%
Remedyrepack Inc.5%
Padagis Israel Pharmaceuticals Ltd5%
Other makers53%

Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

📈 How widely Triamcinolone is used

A general measure of how commonly Triamcinolone is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.

Think of this as a proxy for how widely Triamcinolone is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.

5,724,276
Medicaid prescriptions filled (Q1–Q4 2025)
$83.5M gross Medicaid reimbursement (before mandatory rebates — net cost is lower)

How commonly is Triamcinolone prescribed? Of the 1,597 medications we measure, Triamcinolone ranks #34 by Medicaid prescriptions — more than 98% of them.

Where Triamcinolone ranks among the drugs we measure · Q1–Q4 2025 · neighbors ±5

Utilization by Triamcinolone product

Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.

The 1 mg/mL topical cream is the most-dispensed Triamcinolone product — about 33% of these Medicaid prescriptions.

triamcinolone acetonide 1 MG/ML Topical Cream Most dispensed

1,884,538 Medicaid prescriptions (Q1–Q4 2025) 33% of Triamcinolone prescriptions shown $21.8M gross reimbursement (before rebates) ≈ $12 per prescription (gross)

Summed across the 31 of 152 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1014314

triamcinolone acetonide 0.001 MG/MG Topical Ointment

1,461,206 Medicaid prescriptions (Q1–Q4 2025) 26% of Triamcinolone prescriptions shown $18.5M gross reimbursement (before rebates) ≈ $13 per prescription (gross)

Summed across the 22 of 57 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1085636

triamcinolone acetonide 40 MG/ML Injectable Suspension

759,297 Medicaid prescriptions (Q1–Q4 2025) 13% of Triamcinolone prescriptions shown $13.3M gross reimbursement (before rebates) ≈ $18 per prescription (gross)

Summed across the 18 of 52 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1085754

1 ML triamcinolone acetonide 40 MG/ML Injection

283,078 Medicaid prescriptions (Q1–Q4 2025) 5% of Triamcinolone prescriptions shown $6M gross reimbursement (before rebates) ≈ $21 per prescription (gross)

Summed across the 15 of 44 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1792144

triamcinolone acetonide 0.25 MG/ML Topical Cream

268,688 Medicaid prescriptions (Q1–Q4 2025) 5% of Triamcinolone prescriptions shown $2.6M gross reimbursement (before rebates) ≈ $9.84 per prescription (gross)

Summed across the 14 of 42 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1085644

triamcinolone acetonide 10 MG/ML Injectable Suspension

240,626 Medicaid prescriptions (Q1–Q4 2025) 4% of Triamcinolone prescriptions shown $2.1M gross reimbursement (before rebates) ≈ $8.85 per prescription (gross)

Summed across the 2 of 3 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1085750

triamcinolone acetonide 0.00025 MG/MG Topical Ointment

227,545 Medicaid prescriptions (Q1–Q4 2025) 4% of Triamcinolone prescriptions shown $2.7M gross reimbursement (before rebates) ≈ $12 per prescription (gross)

Summed across the 12 of 17 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1085633

triamcinolone acetonide 5 MG/ML Topical Cream

223,794 Medicaid prescriptions (Q1–Q4 2025) 4% of Triamcinolone prescriptions shown $3.1M gross reimbursement (before rebates) ≈ $14 per prescription (gross)

Summed across the 5 of 29 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1085686

triamcinolone acetonide 0.005 MG/MG Topical Ointment

115,833 Medicaid prescriptions (Q1–Q4 2025) 2% of Triamcinolone prescriptions shown $1.8M gross reimbursement (before rebates) ≈ $16 per prescription (gross)

Summed across the 3 of 13 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1085640

triamcinolone acetonide 0.055 MG/ACTUAT Metered Dose Nasal Spray

99,808 Medicaid prescriptions (Q1–Q4 2025) 2% of Triamcinolone prescriptions shown $1.7M gross reimbursement (before rebates) ≈ $17 per prescription (gross)

Summed across the 7 of 67 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1797913

triamcinolone acetonide 0.001 MG/MG Oral Paste

77,844 Medicaid prescriptions (Q1–Q4 2025) 1% of Triamcinolone prescriptions shown $2M gross reimbursement (before rebates) ≈ $26 per prescription (gross)

Summed across the 4 of 19 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1085728

triamcinolone acetonide 1 MG/ML Topical Lotion

40,427 Medicaid prescriptions (Q1–Q4 2025) <1% of Triamcinolone prescriptions shown $991,332 gross reimbursement (before rebates) ≈ $25 per prescription (gross)

Summed across the 4 of 10 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1085745

triamcinolone acetonide 0.0005 MG/MG Topical Ointment

15,231 Medicaid prescriptions (Q1–Q4 2025) <1% of Triamcinolone prescriptions shown $2.1M gross reimbursement (before rebates) ≈ $141 per prescription (gross)

Summed across the 5 of 11 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1090641

triamcinolone acetonide 0.25 MG/ML Topical Lotion

14,101 Medicaid prescriptions (Q1–Q4 2025) <1% of Triamcinolone prescriptions shown $413,258 gross reimbursement (before rebates) ≈ $29 per prescription (gross)

Summed across the 1 of 7 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1085741

triamcinolone acetonide 32 MG Injection

6,293 Medicaid prescriptions (Q1–Q4 2025) <1% of Triamcinolone prescriptions shown $4M gross reimbursement (before rebates) ≈ $639 per prescription (gross)

Summed across the 1 of 4 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1947131

1 ML triamcinolone acetonide 80 MG/ML Injection

3,411 Medicaid prescriptions (Q1–Q4 2025) <1% of Triamcinolone prescriptions shown $59,141 gross reimbursement (before rebates) ≈ $17 per prescription (gross)

Summed across the 1 of 1 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 2168095

triamcinolone acetonide 80 MG/ML Injectable Suspension

2,202 Medicaid prescriptions (Q1–Q4 2025) <1% of Triamcinolone prescriptions shown $13,602 gross reimbursement (before rebates) ≈ $6.18 per prescription (gross)

Summed across the 1 of 1 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 2168081

triamcinolone acetonide 0.147 MG/ML Topical Spray

301 Medicaid prescriptions (Q1–Q4 2025) <1% of Triamcinolone prescriptions shown $54,948 gross reimbursement (before rebates) ≈ $183 per prescription (gross)

Summed across the 2 of 10 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1085736

0.9 ML triamcinolone acetonide 40 MG/ML Injection

53 Medicaid prescriptions (Q1–Q4 2025) <1% of Triamcinolone prescriptions shown $41,566 gross reimbursement (before rebates) ≈ $784 per prescription (gross)

Summed across the 1 of 5 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 2585221

Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.

Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Triamcinolone, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 149 of 544 listed Triamcinolone NDCs with Medicaid activity.

🔍 Compare Triamcinolone products

A representative set of FDA-listed product records for Triamcinolone — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Showing 200 of 636 products — FDA National Drug Code Directory. See every product, package size and price: browse all 636 Triamcinolone NDCs →

RxNorm Concept Web — From Ingredient to Every Form and Strength

This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.

Ingredient (IN) Triamcinolone RxCUI 10759 10 dose forms · 29 strengths
  1. Dose form (SCDF) Injectable Suspension RxCUI 96818 In current FDA listings
    Clinical drug / strength (SCD) acetonide 10 MG/ML RxCUI 1085750 acetonide 3 MG/ML RxCUI 1085985 acetonide 40 MG/ML RxCUI 1085754 acetonide 80 MG/ML RxCUI 2168081 diacetate 25 MG/ML RxCUI 1085666 diacetate 40 MG/ML RxCUI 1085680 hexacetonide 20 MG/ML RxCUI 1085996
  2. Dose form (SCDF) Metered Dose Nasal Spray RxCUI 1797903 In current FDA listings
    Clinical drug / strength (SCD) acetonide 0.05 MG/ACTUAT RxCUI 1797904 acetonide 0.055 MG/ACTUAT RxCUI 1797913
  3. Dose form (SCDF) Oral Paste RxCUI 10760 In current FDA listings
    Clinical drug / strength (SCD) acetonide 0.001 MG/MG RxCUI 1085728
  4. Dose form (SCDF) Oral Tablet RxCUI 96819 No current FDA listing
    Clinical drug / strength (SCD) 1 MG RxCUI 198301 4 MG RxCUI 198303
  5. Dose form (SCDF) Prefilled Syringe RxCUI 727885 No current FDA listing
    Clinical drug / strength (SCD) 1 ML triamcinolone acetonide 40 MG/ML RxCUI 1086275
  6. Dose form (SCDF) Topical Spray RxCUI 377376 No current FDA listing
    Clinical drug / strength (SCD) acetonide 0.147 MG/ML RxCUI 1085736 acetonide 0.15 MG/ML RxCUI 1805709

Look up RxCUI 10759 in the RxCUI Atlas →

RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.

🏷️ Sold under these brand names

Aristocort Kenacort Kenalog Oralone Triderm Triesence Trianex AllerNaze Nasacort Genesis Zilretta Aller-Cort Hexatrione Xipere Kourzeq triamcinolone acetonide

🏭 Manufacturers & labelers

Bryant Ranch Prepack 65 A-S Medication Solutions 50 NuCare Pharmaceuticals,Inc. 34 Amneal Pharmaceuticals LLC 33 Remedyrepack Inc. 26 Padagis Israel Pharmaceuticals Ltd 23 Proficient Rx LP 21 RPK Pharmaceuticals, Inc. 15 NorthStar RxLLC 14 Macleods Pharmaceuticals Limited 13 Cosette Pharmaceuticals, Inc. 13 Preferred Pharmaceuticals Inc. 12 NorthStar Rx LLC 12 Asclemed USA, Inc. 10 Ascend Laboratories, LLC 9 Crown Laboratories 9 Teva Parenteral Medicines, Inc. 9 Farmabios S.p.A. 9 E.R. Squibb & Sons, L.L.C. 9 Long Grove Pharmaceuticals, LLC 9 Preferred Pharmaceuticals Inc 8 Direct_Rx 7 Preferred Pharmaceuticals, Inc. 7 Quagen Pharmaceuticals Llc 7

…and 16 more on the FDA NDC directory.

RxNorm drug class

Triamcinolone belongs to the Corticosteroid class.

Pharmacologic class Corticosteroid
Drug family (ATC) Corticosteroids for local oral treatment, Corticosteroids, Corticosteroids, moderately potent (group II)
How it works Corticosteroid Hormone Receptor Agonists

Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.

🔬 Where this comes from

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. ✓ Linked label effective Jan 28, 2026
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Triamcinolone.
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.
🧾 Clinical label set — FDA-filed SPL labels retained for Triamcinolone after exact ingredient or ingredient-combination matching and applicable route/form matching
Clinical labels in scope
147
NDC products indexed
636
Distinct labelers/manufacturers represented
134
Linked representative label ⓘ
E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.
Linked label effective
Jan 28, 2026
Composite sections available
16
Linked SPL Set ID
92a1ded0-8e1a-4994-9c8a-89e84fc85c94
Linked SPL Document ID
c8c77210-0a99-47c9-8fe3-0f1531110ffa
Open the linked representative label on DailyMed ↗

How we combine label and product data

HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 147 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.

For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.

This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.